LATEST

• BUSINESS Some Drug Plants Halt Operations after Kumamoto Temblor, Supplies Unaffected
  July 30, 2026

• BUSINESS Leqembi Global Sales Rise to 29.3 Billion Yen in April-June: Eisai
  July 30, 2026

• REGULATORY Pipe Damage Causes Water Leak at Sawai Plant after Quake: MHLW
  July 30, 2026

• REGULATORY MHLW Urges Stable Supply of Drugs after Kumamoto Earthquake
  July 30, 2026

• REGULATORY Kumamoto Quake Hits 46 Medical Facilities; No Pharma Damage Yet: MHLW
  July 29, 2026

• BUSINESS MSD Urges Swift Rollout of Routine HPV Vaccination for Males in Japan
  July 29, 2026

• BUSINESS Drug Makers, Wholesalers Rush to Gauge Kumamoto Quake Impact
  July 29, 2026

• BUSINESS Takeda Files Entyvio IV for Pediatric Use, New Adult Dosing in Japan
  July 29, 2026

• REGULATORY Japan Shifts Mo-99 Supply Strategy toward Stronger Global Procurement: Panel
  July 29, 2026

• REGULATORY 3 Label Expansions Get NHI Coverage on Public Knowledge Pathway
  July 29, 2026

• BUSINESS Otsuka Ups 1H Guidance on Strong Sales, Delayed Generic Competition
  July 29, 2026

• REGULATORY No Cap on FY2027 Budget Requests under Growth Investment Scheme: MOF
  July 29, 2026

• BUSINESS Japan OTC Market Falls for 4th Straight Month in June: Intage
  July 29, 2026

• BUSINESS J-TEC, OSferionBiomaterials Join Forces to Expand Knee OA Business
  July 29, 2026

• BUSINESS FunPep Allergy Vaccine Misses Exploratory Efficacy Goals in PI
  July 29, 2026

• ORGANIZATION Radiopharma Group Seeks Faster NHI Coverage for PET Imaging Agents
  July 28, 2026

• REGULATORY Japan Panel Green-Lights GSK’s Hep B Drug, Brinsupri, Hyrnuo
  July 28, 2026

• BUSINESS Pfizer Brings Eisai into Nurtec Promotion in Japan
  July 28, 2026

• BUSINESS Celltrion, Nippon Kayaku Broaden Alliance in Biopharma Biz
  July 28, 2026

• REGULATORY Japanese Women Top Life Expectancy for 41st Year Running
  July 28, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »